Agenus to Present First Phase 2 Botensilimab Data in Advanced Cutaneous Melanoma at ASCO 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Agenus to Present First Phase 2 Botensilimab Data in Advanced Cutaneous Melanoma at ASCO 2026
AGENUS (NASDAQ: AGEN) Delayed: 3.07 +0.03 (0.99%)
Previous Close $3.04    52 Week High $7.49 
Open $2.99    52 Week Low $2.61 
Day High $3.18    P/E N/A 
Day Low $2.99    EPS $-1.10 
Volume 438,570